Status:
RECRUITING
Establishment of NAFLD Cohort and Development of Fibrosis Markers
Lead Sponsor:
Seoul National University Boramae Hospital
Conditions:
Fibrosis of Liver
Eligibility:
All Genders
18+ years
Brief Summary
This study is designed for establishment of non-alcoholic fatty liver disease patients cohort to development of markers to predict histologic progression of liver fibrosis.
Detailed Description
* Acoustic radiation force impulse elastography and transient elastography * Liver tissue (frozen tissue, paraffin block) * Whole blood, Serum * Fat amount ratio CT (Visceral adipose tissue, Subcutane...
Eligibility Criteria
Inclusion
- Patients with histologically confirmed fatty liver disease
- Patients with radiologically confirmed fatty liver disease
Exclusion
- History of significant alcohol consumption
- Viral hepatitis
- Autoimmune hepatitis
- Metabolic diseases (e.g. hemochromatosis, M. Wilson, alpha 1-antitrypsin deficiency)
- Hepatotoxic medication (e.g. amiodarone)
Key Trial Info
Start Date :
January 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT02206841
Start Date
January 1 2014
End Date
December 31 2030
Last Update
May 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul Metropolitan Government Seoul National University
Seoul, South Korea, 156-707